The temporary allowance for substituting packages in already issued prescriptions has been announced due to supply difficulties with two glaucoma medications, Monoprost Duo and Encil Duofree, which contain latanoprost and timolol. These issues stem from manufacturing constraints affecting the availability of these eye drops.
Medications for glaucoma and ocular hypertension facing supply difficulties
Monday, 16 February 2026RSS
Context & Explainers
Glaucoma is a group of eye conditions that damage the optic nerve, usually associated with raised pressure inside the eye, and can cause irreversible vision loss if untreated. It is a chronic condition managed with pressure‑lowering eye drops, laser therapy, or surgery, so patients should check with their ophthalmologist or pharmacist if prescription substitutions are temporarily allowed.
Ocular hypertension means the pressure inside the eye (intraocular pressure) is higher than normal—typically above about 21 mmHg—without detectable optic nerve damage or visual field loss. It is a risk factor for glaucoma, so doctors usually monitor it regularly and may start treatment to lower pressure if the risk of progression is judged significant.
AI Summary AvailableGlaucoma drugs and ocular-hypertension meds face shortagesRead the synthesized summary with context and explainers
View full article on Correio da Manhã
